Bioptigen

General Information

Company Name

Bioptigen

Founded Year

2004

Location (Offices)

Founders / Decision Makers

Number of Employees

Industries

Biotechnology, Health Care, Medical Devices

Funding Stage

Series Unknown

Social Media

Bioptigen - Company Profile

Bioptigen is an ISO 13485-certified medical device company specializing in creating advanced ophthalmic imaging solutions. The company's Envisu™ R-class systems offer non-invasive imaging capabilities for a wide range of animals, from zebrafish to elephants, using low-power, near-infrared light to produce real-time, high-resolution, volumetric images of eye structures. With CE approval obtained, Bioptigen is positioned to market its hand-held Envisu R2000 systems for preclinical use and C2000 systems for clinical applications within the EU. Since its foundation in 2004, Bioptigen has garnered significant attention within the Biotechnology, Health Care, and Medical Devices industries. The latest notable development for Bioptigen was a $1.50M Venture Round investment on 07 March 2011.

Taxonomy: Ophthalmic Imaging, Near-Infrared Technology, ISO 13485 Certification, Envisu R-Class Systems, Biomedical Imaging, Animal Ocular Imaging, Preclinical Imaging, Clinical Imaging, Zebrafish, Elephants, Volumetric Imaging, CE Approval, Non-Invasive Imaging, Bioptigen Inc.